Mechanism of action
Opium contains multiple naturally occurring alkaloids, with morphine (10-15%) and codeine (1-3%) being the primary active components. The therapeutic effects result from agonism at opioid receptors throughout the central and peripheral nervous systems.
Central effects: Morphine and other alkaloids bind to mu-opioid receptors in the brain and spinal cord, inhibiting ascending pain pathways and altering pain perception. This produces analgesia, euphoria, and central nervous system depression. Mu-receptor activation in the medullary respiratory center decreases respiratory drive, the basis for respiratory depression toxicity.
Peripheral gastrointestinal effects: Opioid receptors in the myenteric and submucosal plexuses of the gastrointestinal tract mediate the antidiarrheal action. Activation increases circular muscle tone, decreases propulsive peristalsis, and increases fluid absorption from the intestinal lumen. The pyloric sphincter and ileocecal valve exhibit increased tone, further slowing transit. Opium also reduces secretions from the pancreas, biliary tract, and intestinal mucosa.
Other alkaloids: Papaverine, a minor component, has direct smooth muscle relaxant properties through phosphodiesterase inhibition but contributes minimally to clinical effects at therapeutic doses. Thebaine has minimal opioid activity and serves primarily as a precursor for semisynthetic opioid synthesis.
- Opium acts via mu-opioid receptor agonism, producing analgesia centrally and reducing gut motility peripherally
- Primary components are morphine (10-15%) and codeine (1-3%) with distinct pharmacokinetic profiles
- Respiratory depression is the most dangerous acute adverse effect, reversed by naloxone
- Constipation occurs in nearly all patients and does not exhibit significant tolerance
- Miosis (pinpoint pupils) is a classic physical finding of opioid intoxication
- Contraindicated in paralytic ileus, acute abdomen, and severe respiratory depression
- Schedule II controlled substance with high potential for physical and psychological dependence
- Chronic maternal use causes neonatal abstinence syndrome requiring treatment after delivery
Indications
Opium has limited modern clinical use due to the availability of more specific and predictable opioid formulations.
Primary indications:
- Severe acute diarrhea: Used as an antidiarrheal when other agents are ineffective, particularly in combination products. The paregoric formulation (camphorated opium tincture) was historically common but has largely been replaced by synthetic opioids like loperamide and diphenoxylate.
- Neonatal abstinence syndrome: Diluted opium tincture is used in some protocols for managing opioid withdrawal in neonates born to opioid-dependent mothers. It provides a mixture of opioid alkaloids that can be gradually tapered.
- Severe pain: Rarely used for analgesia in modern practice, as purified morphine and other opioids offer more predictable pharmacokinetics and dosing.
Historical uses: Opium was once widely used for cough suppression, dysentery, and various painful conditions before the development of purified and synthetic opioids. Its unpredictable alkaloid content and high abuse potential have relegated it to very limited therapeutic roles in contemporary medicine.
Pharmacokinetics
The pharmacokinetics of opium are complex due to its multi-component nature, with each alkaloid exhibiting distinct properties.
Absorption: Oral administration leads to variable absorption of different alkaloids. Morphine undergoes significant first-pass hepatic metabolism, resulting in 20-30% bioavailability. Codeine has higher oral bioavailability (50-60%). Absorption from the gastrointestinal tract is influenced by gut motility, which opium itself reduces.
Distribution: Morphine and codeine distribute widely throughout the body, crossing the blood-brain barrier to produce central effects. Morphine is less lipophilic than many synthetic opioids, resulting in slower CNS penetration. Volume of distribution for morphine is approximately 3-4 L/kg. Both alkaloids cross the placenta and are excreted in breast milk.
Metabolism: Hepatic metabolism via glucuronidation is the primary elimination pathway for morphine, producing morphine-3-glucuronide (inactive) and morphine-6-glucuronide (active analgesic). Codeine undergoes O-demethylation by CYP2D6 to morphine (10% of dose), contributing to its analgesic effects. Genetic polymorphisms in CYP2D6 significantly affect codeine efficacy and toxicity.
Elimination: Metabolites are excreted primarily in urine, with smaller amounts in bile. Morphine has an elimination half-life of 2-4 hours. Renal impairment prolongs elimination of active metabolites, increasing toxicity risk. The antidiarrheal effects persist longer than plasma concentrations suggest due to local GI receptor occupancy.
Adverse effects
Opium shares the adverse effect profile of all opioid agonists, with effects proportional to the morphine content.
Central nervous system:
- Respiratory depression: Dose-dependent decrease in respiratory rate and tidal volume, the most dangerous acute effect. Risk increases with concurrent CNS depressants.
- Sedation, drowsiness, and cognitive impairment
- Euphoria or dysphoria
- Miosis (pinpoint pupils), a classic opioid sign
- Dizziness and confusion, especially in elderly patients
Gastrointestinal:
- Constipation: Nearly universal with chronic use, resulting from decreased motility and increased sphincter tone
- Nausea and vomiting from chemoreceptor trigger zone stimulation
- Biliary colic from sphincter of Oddi spasm
- Delayed gastric emptying
Cardiovascular: Orthostatic hypotension from peripheral vasodilation and histamine release. Bradycardia may occur with high doses.
Genitourinary: Urinary retention from increased bladder sphincter tone and decreased detrusor contractility. Reduced libido and hypogonadism with chronic use.
Tolerance and dependence: Physical dependence develops with regular use, leading to withdrawal symptoms upon discontinuation. Symptoms include anxiety, sweating, myalgias, diarrhea, and drug craving. Psychological dependence and addiction potential are significant.
Hypersensitivity: Pruritus and urticaria from histamine release. True allergic reactions are rare but can include bronchospasm and anaphylaxis.
Neonatal effects: Chronic maternal use causes neonatal abstinence syndrome with irritability, tremors, vomiting, diarrhea, and seizures.
Contraindications and warnings
Absolute contraindications:
- Known hypersensitivity to opium alkaloids or any formulation component
- Acute or severe bronchial asthma in unmonitored settings
- Paralytic ileus or suspected gastrointestinal obstruction
- Acute abdomen requiring surgical evaluation (masks peritoneal signs)
- Severe respiratory depression or hypercapnia
Relative contraindications and warnings:
- Respiratory disease: Chronic obstructive pulmonary disease, cor pulmonale, decreased respiratory reserve. Use with extreme caution and monitoring.
- Head injury or increased intracranial pressure: Respiratory depression causes CO₂ retention and cerebral vasodilation, worsening intracranial hypertension. Miosis and sedation obscure neurological assessment.
- Hepatic impairment: Reduced metabolism increases toxicity risk; dose adjustment required.
- Renal impairment: Accumulation of active metabolites, particularly morphine-6-glucuronide, increases adverse effects.
- Elderly patients: Increased sensitivity to CNS and respiratory effects; start with reduced doses.
- Infectious diarrhea: May prolong illness by reducing elimination of pathogens and toxins; avoid in bloody diarrhea or fever suggesting invasive organisms.
- Prostatic hypertrophy or urethral stricture: Exacerbates urinary retention.
Pregnancy and lactation: Pregnancy category C (historical classification). Chronic use causes neonatal dependence and withdrawal. Use only when benefits clearly outweigh risks. Opium alkaloids enter breast milk; breastfeeding infants may experience sedation and respiratory depression.
Controlled substance: Opium is a Schedule II controlled substance in the United States due to high abuse potential. Prescribing requires careful documentation and monitoring.
Drug interactions
Opium interactions reflect the properties of its constituent alkaloids, primarily morphine and codeine.
CNS depressants: Additive or synergistic respiratory depression and sedation occur with:
- Benzodiazepines
- Barbiturates
- Alcohol
- General anesthetics
- Other opioids
- Sedating antihistamines
- Antipsychotics
Combination significantly increases overdose risk and should be avoided or carefully monitored.
Monoamine oxidase inhibitors (MAOIs): Severe and unpredictable potentiation of opioid effects, including respiratory depression, hypotension, and coma. The mechanism involves decreased opioid metabolism and potentiation of serotonergic effects. Opium should be avoided within 14 days of MAOI use.
Anticholinergic drugs: Additive effects on gastrointestinal motility increase constipation and paralytic ileus risk. Combined use with anticholinergic agents (antihistamines, tricyclic antidepressants, antispasmodics) may cause severe constipation or urinary retention.
CYP2D6 interactions: Codeine requires CYP2D6 for conversion to morphine. Inhibitors (fluoxetine, paroxetine, quinidine) reduce analgesic efficacy. Ultra-rapid metabolizers (genetic polymorphism) convert more codeine to morphine, increasing toxicity risk.
Muscle relaxants: Enhanced neuromuscular blockade and respiratory depression.
Antihypertensives: Additive hypotensive effects, particularly orthostatic hypotension.
Rifampin: Enzyme inducer that increases morphine metabolism, potentially reducing analgesic effects with chronic co-administration.
Serotonergic drugs: Combination with SSRIs, SNRIs, triptans, or MAOIs may precipitate serotonin syndrome, though the risk is lower with opium than with synthetic opioids like tramadol or meperidine.
Clinical pearls
Exam associations: Opium questions often test knowledge of mu-opioid receptor effects, distinguishing central from peripheral actions, or recognizing neonatal abstinence syndrome. Remember that the antidiarrheal effect results from peripheral opioid receptors in the gut, not central mechanisms.
Morphine vs codeine content: The variable alkaloid composition makes opium less predictable than purified opioids. Morphine content typically ranges from 10-15%, but standardization varies by preparation.
Paregoric distinction: Camphorated opium tincture (paregoric) contains 0.4 mg/mL morphine equivalent, whereas deodorized opium tincture contains 10 mg/mL. Confusion between these preparations has caused fatal overdoses. Always verify concentration before administration.
Neonatal abstinence syndrome: Diluted opium tincture remains part of some treatment protocols, but methadone and buprenorphine are increasingly preferred for more predictable pharmacokinetics. When used, careful dilution and dosing are essential.
Masking surgical abdomen: A classic teaching point is that opioids should not be given for undifferentiated abdominal pain before surgical evaluation, as they mask peritoneal signs (rebound tenderness, guarding) needed for diagnosis.
Overdose management: Naloxone rapidly reverses opioid toxicity, including respiratory depression. However, naloxone has a shorter half-life than morphine, requiring repeated dosing or infusion to prevent re-narcotization. In opioid-dependent patients, naloxone precipitates acute withdrawal.
Constipation prevention: Unlike tolerance to other opioid effects, tolerance to constipation develops minimally. Prophylactic bowel regimen with stimulant laxatives and stool softeners is essential for chronic use.
Historical significance: Understanding opium's role in medical history provides context for modern opioid pharmacology and the opioid crisis. The purification of morphine in 1804 marked the beginning of alkaloid chemistry and modern pharmacology.
Practice questions
1. A 3-day-old infant born to a mother with known opioid use disorder presents with irritability, tremors, high-pitched crying, and loose stools. Physical examination reveals tachypnea, sneezing, and increased muscle tone. The pediatric team considers starting pharmacologic treatment. Which mechanism best explains the therapeutic effect of diluted opium tincture in this condition?
2. A 68-year-old man with chronic pain receives opium tincture for pain management. After 2 weeks, he develops severe constipation requiring medical intervention despite using over-the-counter laxatives. He reports that his pain control remains adequate with the same dose. Which statement best explains the persistence of his constipation while analgesia is maintained?
3. A 45-year-old woman with severe diarrhea receives opium tincture in the emergency department. Thirty minutes after administration, she develops altered mental status, respiratory rate of 8/min, and pinpoint pupils. Oxygen saturation is 85% on room air. Which medication should be administered immediately?
Frequently asked questions
How does opium work?
Opium works primarily through agonism at mu-opioid receptors in the central nervous system and gastrointestinal tract. In the CNS, it inhibits pain pathways and produces analgesia, while in the gut, it reduces peristalsis and increases fluid absorption, making it effective for diarrhea. The main active components responsible for these effects are morphine and codeine, which comprise 10-15% and 1-3% of crude opium respectively.
What are the side effects of opium?
The most serious side effect is respiratory depression, which can be life-threatening. Common side effects include constipation (occurs in nearly all users), nausea, vomiting, sedation, dizziness, and miosis (pinpoint pupils). Chronic use leads to physical dependence and tolerance, with withdrawal symptoms developing upon discontinuation. Other effects include urinary retention, orthostatic hypotension, pruritus from histamine release, and cognitive impairment, particularly in elderly patients.
Is opium a controlled substance?
Yes, opium is classified as a Schedule II controlled substance in the United States due to its high potential for abuse and dependence. This classification means it has recognized medical uses but carries significant risk of physical and psychological dependence. Prescribing requires special DEA registration, careful documentation, and adherence to strict regulatory requirements. The high abuse potential stems from the euphoric effects produced by morphine and other alkaloids acting on central opioid receptors.
Can opium be used during pregnancy?
Opium should only be used during pregnancy when benefits clearly outweigh risks. It crosses the placenta, and chronic maternal use causes neonatal abstinence syndrome after delivery, characterized by irritability, tremors, vomiting, diarrhea, and potentially seizures in the newborn. There is no evidence of teratogenic effects, but neonatal respiratory depression can occur if administered near delivery. When medically necessary, the lowest effective dose for the shortest duration should be used, and neonatal monitoring should be planned.
Opium vs morphine — what is the difference?
Opium is a crude natural mixture of alkaloids extracted from the poppy plant, containing 10-15% morphine along with codeine, thebaine, papaverine, and other compounds. Morphine is a single purified alkaloid isolated from opium with predictable pharmacokinetics and dosing. Morphine is preferred in modern medicine because its effects are more consistent and controllable. Opium's variable alkaloid composition makes dosing less predictable, though it retains limited use for neonatal abstinence syndrome and severe diarrhea in some settings.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A07DA02WHO ATC/DDD index: N02AA02
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.